Sonoma Pharmaceuticals, Inc. is making waves in wound, animal, eye, oral, and dermatological care with its innovative stabilized hypochlorous acid (HOCl) products. With a presence in the United States, Latin America, Europe, and beyond, the company offers a range of products to manage and relieve conditions like dermatoses, seborrhea, seborrheic dermatitis, and more. Its products include Epicyn, an antimicrobial facial cleanser, Levicyn for itch relief, Celacyn gel to manage scars, SebuDerm for seborrhea and seborrheic dermatitis, and Acuicyn to relieve inflammation around the eyes. Sonoma Pharmaceuticals also offers Microcyn, a line of topical products designed to stimulate expedited healing, MicrocynAH for animal skin relief, and Endocyn for root canal irrigation solutions. Additionally, its product line includes Nanocyn, a hospital-grade disinfectant, Gramaderm for mild to moderate acne treatment, and Sinudox for nasal irrigation. The company, formerly known as Oculus Innovative Sciences, Inc., changed its name to Sonoma Pharmaceuticals, Inc. in 2016 and is based in Woodstock, Georgia.
Sonoma Pharmaceuticals, Inc.'s ticker is SNOA
The company's shares trade on the NASDAQ stock exchange
They are based in Petaluma, California
There are 11-50 employees working at Sonoma Pharmaceuticals, Inc.
It is https://sonomapharma.com/
Sonoma Pharmaceuticals, Inc. is in the Healthcare sector
Sonoma Pharmaceuticals, Inc. is in the Drug Manufacturers - Major industry
The following five companies are Sonoma Pharmaceuticals, Inc.'s industry peers: